facebook-page-view
Advertisement

pathology

Premium
OrbiMed backed Suraksha Diagnostic hires banker for fresh fundraise; may consider IPO

Healthcare

08 February, 2022

OrbiMed backed Suraksha Diagnostic hires banker for fresh fundraise; may consider IPO

Suraksha Diagnostic Pvt. Ltd has hired investment banking firm JM Financial for a fresh fundraise that will also pave the ......

Premium
TA Associates-backed Indira IVF to diversify into pathology biz

Healthcare

24 January, 2022

TA Associates-backed Indira IVF to diversify into pathology biz

Infertility treatment provider Indira IVF Hospital Pvt. Ltd, which is backed by private equity firm TA Associates, is set to ......

Metropolis to buy majority stake in another Gujarat-based diagnostics firm

Healthcare

16 January, 2020

Metropolis to buy majority stake in another Gujarat-based diagnostics firm

Pathology chain Metropolis Healthcare Ltd, which went public last year, will acquire a majority stake in another diagnostics firm in ......

WestBridge-backed Dr Lal PathLabs to acquire majority stake in Indore lab

Healthcare

14 June, 2019

WestBridge-backed Dr Lal PathLabs to acquire majority stake in Indore lab

Diagnostics chain Dr Lal PathLabs Ltd said on Friday it will acquire a 70% stake in a new company that ......

Carlyle-backed Metropolis' IPO subscribed almost six times on final day

Healthcare

05 April, 2019

Carlyle-backed Metropolis' IPO subscribed almost six times on final day

Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) was subscribed almost six times on the third and final ......

Carlyle-backed Metropolis Healthcare's IPO nears halfway mark on second day

Healthcare

04 April, 2019

Carlyle-backed Metropolis Healthcare's IPO nears halfway mark on second day

Pathology chain owner Metropolis Healthcare Ltd’s initial public offering (IPO) nearly reached the halfway mark on its second day on ......

Premium
Value Lens: How does Metropolis Healthcare size up against listed peers?

Healthcare

29 March, 2019

Value Lens: How does Metropolis Healthcare size up against listed peers?

When Metropolis Healthcare Ltd goes public next week, it will become the third diagnostics chain to launch an initial public ......

Premium
Tracing Carlyle's returns from partial exit in Metropolis' upcoming IPO

Healthcare

28 March, 2019

Tracing Carlyle's returns from partial exit in Metropolis' upcoming IPO

US-headquartered private equity giant The Carlyle Group appears likely to score modest returns from the sale of a little more ......

Premium
Suburban Diagnostics to draw up exit plan for early investor Sequoia

Healthcare

17 October, 2018

Suburban Diagnostics to draw up exit plan for early investor Sequoia

Mumbai-based pathology chain Suburban Diagnostics India Pvt. Ltd will continue to explore inorganic growth opportunities while also firming up plans ......

Premium
Pathology chain operator Metropolis ends JV with Sri Lankan partner

Healthcare

15 December, 2017

Pathology chain operator Metropolis ends JV with Sri Lankan partner

Pathology chain operator Metropolis Healthcare has ended its over 10-year-long joint venture with its Sri Lankan partner and has decided ......